Next fiscal year's sales in the electrolyzed-water dialysis business: ¥200 million
First written in FY2018-Q2. 10 of 14 entries say "Advanced", first in FY2020-Q1. Latest entry: 2026-05-13.
No other company in this theme has enough history to compare yet.
- 2026-05-13RestatedEarnings presentation
「Electrolyzed-water dialysis business 102 0.4% 200 0.7% +97 +95.2%」
For the electrolyzed-water dialysis business, the company projects FY2027 revenue of ¥200 million versus actual revenue of ¥102 million in FY2026. - FY2024SoftenedAnnual report
「In the electrolyzed water dialysis business, 4 facilities originally expected to be installed during the current fiscal year were postponed to the next fiscal year or later due to circumstances on the facilities’ side. As a result, installation was limited to multi-patient systems at 2 facilities, Shonan Kamakura General Hospital of the Tokushukai Group and Tokyo Nephro Clinic, and revenue was ¥60 million, down 48.0% year on year.」
Against the plan for sales of ¥200 million and implementation at 10 facilities next fiscal year, implementation at 4 facilities was postponed to next fiscal year or later, resulting in implementation at 2 facilities and sales of only ¥60 million during the current fiscal year. - FY2023RestatedAnnual report
「For next fiscal year, we plan sales of ¥200 million from 10 facilities.」
For electrolyzed water dialysis, the company reconfirmed its plan to introduce the system at 10 facilities and generate sales of ¥200 million next fiscal year. - FY2023-Q2AdvancedAnnual report
「In the first half, the system was newly introduced at 2 facilities, while 6 facility introductions are currently planned for the second half. From next fiscal year onward, we are also submitting quotations to more than 60 facilities and conducting detailed negotiations.」
Toward expanding sales of electrolyzed water dialysis, the company reported progress on projects involving implementation at 2 facilities in the first half, planned implementation at 6 facilities in the second half, and negotiations with more than 60 facilities from next fiscal year onward. - FY2023-Q1AdvancedAnnual report
「We are preparing quotations at the request of 69 facilities, representing total potential sales of approximately ¥1.3 billion, and are in negotiations. There are approximately 4,500 dialysis facilities in Japan, and we will continue to focus on expanding adoption.」
For electrolyzed water dialysis, the number of facilities targeted for sales negotiations increased to 69, with total potential sales of approximately ¥1.3 billion, from the previous 57–58 facilities and approximately ¥1.1–1.2 billion. - FY2022AdvancedAnnual report
「At the request of 58 facilities that could potentially introduce the system within 2 years, we have submitted quotations totaling approximately ¥1.2 billion and are proceeding with sales negotiations. For next fiscal year, we plan sales of ¥207 million from 10 facilities.」
In the electrolyzed water dialysis business, the company advanced to sales negotiations involving 58 facilities that could potentially introduce the system within 2 years, totaling approximately ¥1.2 billion, and presented a plan for 10 facilities and sales of ¥207 million next fiscal year. - FY2022-Q3AdvancedAnnual report
「We have submitted quotations to 57 facilities, with which detailed negotiations are currently under way and where contracts are highly likely to be concluded within 2 years, representing total potential sales of approximately ¥1.1 billion.」
Toward expanding sales in the electrolyzed water dialysis business, the company advanced to the stage of submitting quotations for projects involving 57 facilities with a high likelihood of contracts being concluded within 2 years, representing total potential sales of approximately ¥1.1 billion. - FY2021-Q2AdvancedAnnual report
「In the electrolyzed water dialysis business, following the installation in June of a multi-patient electrolyzed water dialysis system with 45 beds at St. Luke’s International Hospital, 2 systems were installed in August at a major dialysis hospital in the Tokai region, with capacities of 90 beds and 63 beds.」
The introduction of electrolyzed water dialysis expanded to multiple facilities, including core hospitals, building an implementation track record toward the sales target for next fiscal year. - FY2021-Q1AdvancedAnnual report
「In the electrolyzed water dialysis business, a multi-patient electrolyzed water dialysis system was installed in June at St. Luke’s International Hospital, a core facility in the Kanto region. Significant follow-on effects are expected.」
Toward its target for the broader adoption of electrolyzed water dialysis, the company made concrete progress by introducing a multi-patient system at St. Luke’s International Hospital, a core facility in the Kanto region. - FY2020AdvancedAnnual report
「In the electrolyzed water dialysis business, as a result of a joint paper with Tohoku University and efforts to highlight the improvement in hospital profitability from introducing electrolyzed water dialysis, the system was introduced at 9 facilities during the current fiscal year, generating sales of ¥139 million, up 755.9% year on year.」
In connection with the ¥200 million sales target for next fiscal year, the company reported current-year sales of ¥139 million, up 755.9% year on year, and implementation at 9 facilities. - FY2020-Q3AdvancedAnnual report
「In the electrolyzed water dialysis business, the system was introduced at 8 facilities during the current fiscal year. Currently, approximately 1,500 patients at 22 facilities in Japan are receiving electrolyzed water dialysis treatment. Inquiries from hospitals continue to increase, and we are currently in detailed negotiations with more than 20 facilities from the fourth quarter through next fiscal year.」
In connection with the ¥200 million sales target for next fiscal year, the system was introduced at 8 facilities during the current fiscal year, with treatment delivered at 22 facilities in Japan to approximately 1,500 patients. Detailed negotiations are under way with more than 20 facilities from the fourth quarter through next fiscal year. - FY2020-Q2AdvancedAnnual report
「The electrolyzed water dialysis business has begun generating results, with revenue of ¥91 million. We are actively developing sales during the second half and from the next fiscal year onward to further expand performance. We are in discussions with approximately 100 facilities for installation within 3 years; if contracts are concluded with all of them, sales would be approximately ¥2.8 billion.」
The electrolyzed water dialysis business generated sales of ¥91 million and progressed to negotiations with approximately 100 facilities, worth approximately ¥2.8 billion, for implementation within 3 years. - FY2020-Q1AdvancedAnnual report
「Orders and contracts totaling approximately ¥100 million have been secured for first-half sales, and sales activities are being expanded further.」
In the electrolyzed water dialysis business, orders and contracts totaling approximately ¥100 million have been secured for first-half sales, indicating progress in sales efforts toward the ¥200 million sales target for next fiscal year. - FY2018-Q2First statedAnnual report
「Electrolyzed water dialysis can make a significant contribution to improving dialysis patients’ quality of life. Benefits for hospital management have also been reported, including lower labor costs through reduced workloads for nurses and technicians, as well as lower drug costs. We are targeting sales of ¥200 million next fiscal year.」
For electrolyzed water dialysis, the company has highlighted the benefits for hospital management and presented a sales target of ¥200 million for next fiscal year for the first time.